Tech Company Financing Transactions
Millendo Therapeutics Funding Round
5AM Ventures, Frazier Technology Ventures and private investors participated in a $6.5 million capital raise for Millendo Therapeutics. The funding round was announced by the company on 6/30/2014.
Transaction Overview
Company Name
Announced On
6/30/2014
Transaction Type
Venture Equity
Amount
$6,450,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
110 Miller Ave. 100
Ann Arbor, MI 48104
USA
Ann Arbor, MI 48104
USA
Phone
Website
Email Address
Overview
Millendo Therapeutics is focused on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. Our product candidates seek to improve the quality of life for patients with orphan and specialty diseases with limited or no approved treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julia Owens
Chief Financial Officer
Louis Arcudi
Chief Medical Officer
Christophe Arbet-Engels
VP - Bus. Development
Thomas Hoover
VP - Bus. Development
Ryan Zeidan
VP - General Counsel
Tamara Joseph
Browse more venture capital transactions:
Prev: 6/30/2014: Inception 5 venture capital transaction
Next: 6/30/2014: Moontoast venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs